
|Videos|July 4, 2021
Dr. Ramasamy discusses investigational oral testosterone treatment
Author(s)Urology Times staff
Ranjith Ramasamy, MD, comments on SOV2012-F1 (Kyzatrex), an oral testosterone undecanoate soft gelatin capsule.
Advertisement
In this video, Ranjith Ramasamy, MD, discusses SOV2012-F1 (Kyzatrex), an oral testosterone undecanoate soft gelatin capsule for which the FDA recently accepted a new drug application. Ramasamy is an associate professor of urology and director of male reproductive medicine and surgery at the University of Miami Miller School of Medicine.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
2
FDA greenlights phase 1 study of UGN-501 for NMIBC
3
Trial launches of actinium (225Ac) rhPSMA-10.1 injection in mCRPC
4
Urocross shows sustained benefit through 24 months post-removal
5












